To investigate this, we analysed the correlation between key transcription factors in the EMT pathway—ZEB1, ZEB2, TWIST and SNAI1—and RBM6 using prostate cancer data from the cBioPortal database (Prostate Adenocarcinoma, TCGA, Cell 2015, https://www.cbioportal.org/). This evidence concerns the gene RBM6 and prostate adenocarcinoma.